Sinphar Pharmaceutical Co Ltd (1734) – Strategy, SWOT and Corporate Finance Report
- Pages: 38
- Published: July 2023
- Report Code: MLPH81945FSA
Sinphar Pharmaceutical Co Ltd (1734) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company which carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements among others. It also has several products in pipeline addressing dementia, dry age related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada, and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.
Scope
• Detailed information on Sinphar Pharmaceutical Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Sinphar Pharmaceutical Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Sinphar Pharmaceutical Co Ltd including a breakdown and examination of key business segments
• News about Sinphar Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Sinphar Pharmaceutical Co Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Sinphar Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Sinphar Pharmaceutical Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Taiwan Biotech Co Ltd
Sunty Development Co Ltd
ScinoPharm Taiwan Ltd
DURECT Corp
Abnova Corp
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.